Skip to main content

Table 3 Subgroup Analysis of Clinical Outcomes in ABAO Patients

From: Endovascular treatment for acute basilar artery occlusion: a single center retrospective observational study

Outcome variables

Subgroups

Tandem lesion

ICAS

ASITN/SIR collateral system

Prior use of intravenous tPA

Yes (n = 25)

No (n = 162)

P value

Yes (n = 117)

No (n = 70)

P value

Grade 0–2 (n = 165)

Grade 3–4 (n = 22)

P value

Yes (n = 36)

No (n = 151)

P value

Successful recanalization (mTICI 2b-3)

15 (60.0)

143 (88.3)

<  0.01

100 (85.5)

58 (82.9)

0.63

137 (83.0)

21 (95.5)

0.21

30 (83.3)

128 (84.8)

0.80

Complete recanalization (mTICI 3)

13 (52.0)

113 (69.8)

0.11

77 (65.8)

49 (70.0)

0.55

108 (65.5)

18 (81.8)

0.15

26 (72.2)

100 (66.2)

0.49

Hemorrhagic transformation within 24 h

4 (16.0)

25 (15.4)

>  0.99

16 (13.7)

13 (18.6)

0.37

26 (15.8)

3 (13.6)

>  0.99

7 (19.4)

22 (14.6)

0.45

SICH (ECASS III definition) within 24 h

2 (8.0)

6 (3.7)

0.29

4 (3.4)

4 (5.7)

0.48

7 (4.2)

1 (4.6)

>  0.99

1 (2.8)

7 (4.6)

>  0.99

Functional independence (mRS 0–2) at 90 days

7 (28.0)

61 (37.7)

0.38

43 (36.8)

25 (35.7)

0.89

55 (33.3)

13 (59.1)

0.03

15 (41.7)

53 (35.1)

0.46

Favorable outcome (mRS 0–3) at 90 days

8 (32.0)

84 (51.9)

0.07

62 (53.0)

30 (42.9)

0.18

75 (45.5)

17 (77.3)

0.01

19 (52.8)

73 (48.3)

0.63

Mortality at 90 days

11 (44.0)

27 (16.7)

0.01

20 (17.1)

18 (25.7)

0.16

36 (21.8)

2 (9.1)

0.26

6 (16.7)

32 (21.2)

0.65

  1. Abbreviations: ASITN/SIR American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology, ECASS European Cooperative Acute Stroke Study, ICAS intracranial atherosclerotic stenosis, mRS modified Rankin Scale, mTICI modified Thrombolysis in Cerebral Infarction, SICH symptomatic intracerebral hemorrhage, tPA tissue Plasminogen Activator